Last reviewed · How we verify
NCT05935345
Addressing Nonsuicidal Self-injury in Schools
NA trial testing Addressing NSSI in schools in Nonsuicidal Self-injury in 267 participants. Completed in 12 June 2023.
12 June 2023
Quick facts
| Lead sponsor | Region Östergötland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 267 |
| Start date | 10 January 2022 |
| Primary completion | 12 June 2023 |
| Estimated completion | 12 June 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Addressing NSSI in schools
- Control condition
Conditions studied
- Nonsuicidal Self-injury — all drugs for Nonsuicidal Self-injury →
- Suicidal Ideation — all drugs for Suicidal Ideation →
- Stigmatization — all drugs for Stigmatization →
- Help-Seeking Behavior — all drugs for Help-Seeking Behavior →
Sponsor
Region Östergötland
Who can join
Adults 13 to 15, any sex, with Nonsuicidal Self-injury or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to study the effectiveness of a whole-school approach that addresses non-suicidal self-injury and targets adolescents, parents and teachers. Whether training and interventions can influence NSSI will be examined. Furthermore, investigations will be conducted to examine whether this whole-school approach can reduce symptoms of mental health problems in adolescents, reduce stigma och increase help-seeking and perception of social support. Using a clustered waitlist control design, six lower secondary schools were randomized to either intervention or waitlist during four months (control groups were then given the intervention). Measures of NSSI, suicidality, mental well-being, stigma, attitudes, help-seeking and perceived social support were administered at baseline, after the intervention and at 6, 12 and 18-months follow-up. Two hundred and sixty-seven adolescents in seventh and eight grade participated in the study (135 active group and 132 control group). The interventions were delivered during four months. For adolescents, interventions were delivered in the class room and consisted of five sessions of the Youth Aware of Mental Health (YAM) program and one additional session focusing specifically on knowledge, stigma and attitudes toward NSSI (KRAS). Parents were offered an online psychoeducation on NSSI, as were all school staff during this time period. School health care personnel, nurses, psychologist and counsellors and other school staff, such as teachers' aids, support staff and mentors took part in a 2-day workshop on NSSI and suicidality.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of a Whole-School Prevention Program Targeting Mental Health and Nonsuicidal Self-Injury in Swedish Adolescents: A Cluster-Randomized Experimental Study with Longitudinal Follow-Up.
Aspeqvist E, Korhonen L, Dahlström Ö, Andersson H, et al · · 2026 · PMID 40932580 · DOI 10.1007/s10964-025-02251-3
Verify or expand the search:
- PubMed search for NCT05935345
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Region Östergötland trials
Trials by the same sponsor.
- NCT06346535 — PrimeCog: Primary Care Cognitive Testing · recruiting
- NCT06276192 — Digital Physiotherapy Treatment for Patients With Subacromial Pain Compared to Usual Physiotherapy in Primary Care · NA · not yet recruiting
- NCT07159516 — Identifying Birth-Related PTSD: Cutoffs for the City Birth Trauma Scale · completed
- NCT06659822 — Responding to Elder Abuse in GERiAtric Care - Dementia · completed
- NCT05782582 — Chronic Coronary Syndrome in Swedish Primary Care · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05935345 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Östergötland
- Last refreshed: 7 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05935345.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing